366 related articles for article (PubMed ID: 9624474)
1. beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa.
Pitout JD; Thomson KS; Hanson ND; Ehrhardt AF; Moland ES; Sanders CC
Antimicrob Agents Chemother; 1998 Jun; 42(6):1350-4. PubMed ID: 9624474
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.
Park SD; Uh Y; Lee G; Lim K; Kim JB; Jeong SH
APMIS; 2010 Oct; 118(10):801-8. PubMed ID: 20854475
[TBL] [Abstract][Full Text] [Related]
3. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
Moland ES; Sanders CC; Thomson KS
J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
[TBL] [Abstract][Full Text] [Related]
4. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
Rzeczkowska M; Piekarska K; Gierczyński R
Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
[TBL] [Abstract][Full Text] [Related]
6. Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials.
Jones CH; Tuckman M; Keeney D; Ruzin A; Bradford PA
Antimicrob Agents Chemother; 2009 Feb; 53(2):465-75. PubMed ID: 19015360
[TBL] [Abstract][Full Text] [Related]
7. Prevalence study of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking inducible ampC from Saudi hospitals.
Abdalhamid B; Albunayan S; Shaikh A; Elhadi N; Aljindan R
J Med Microbiol; 2017 Sep; 66(9):1286-1290. PubMed ID: 28820112
[TBL] [Abstract][Full Text] [Related]
8. Transfer of resistance to oxy-imino-cephalosporins and of extended-spectrum beta-lactamase productions in Klebsiella pneumoniae strains from infected neonates.
Blahová J; Hupková M; Králiková K; Krcméry V; Lísková A; Kubonová K
Zentralbl Bakteriol; 1998 Jul; 288(1):75-86. PubMed ID: 9728407
[TBL] [Abstract][Full Text] [Related]
9. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
Tan TY; Ng SY; Teo L; Koh Y; Teok CH
J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
[TBL] [Abstract][Full Text] [Related]
10. A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coli.
Mirelis B; Rivera A; Miró E; Mesa RJ; Navarro F; Coll P
Enferm Infecc Microbiol Clin; 2006; 24(6):370-2. PubMed ID: 16792938
[TBL] [Abstract][Full Text] [Related]
11. Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients.
Giani T; Antonelli A; Caltagirone M; Mauri C; Nicchi J; Arena F; Nucleo E; Bracco S; Pantosti A; ; Luzzaro F; Pagani L; Rossolini GM
Euro Surveill; 2017 Aug; 22(31):. PubMed ID: 28797330
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center.
Coudron PE; Moland ES; Thomson KS
J Clin Microbiol; 2000 May; 38(5):1791-6. PubMed ID: 10790101
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints.
Wang P; Hu F; Xiong Z; Ye X; Zhu D; Wang YF; Wang M
J Clin Microbiol; 2011 Sep; 49(9):3127-31. PubMed ID: 21752977
[TBL] [Abstract][Full Text] [Related]
14. [CMY-2-type plasmid-mediated AmpC ß-lactamases emerging in Tucumán, Argentina].
Jure MA; Presti C; Cudmani NM; Grellet LM; López C; Musa EH; Aulet OC; Nieto C; Saavedra L; de Castillo MC
Rev Argent Microbiol; 2011; 43(1):24-7. PubMed ID: 21491062
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a double synergy differential test (DSDT) for differential detection of ESBL and AmpC-type β-lactamases in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
Sabia C; Gargiulo R; Sarti M
New Microbiol; 2012 Apr; 35(2):221-5. PubMed ID: 22707136
[TBL] [Abstract][Full Text] [Related]
16. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
Mohanty S; Gaind R; Ranjan R; Deb M
J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
[TBL] [Abstract][Full Text] [Related]
17. Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs).
Rajivgandhi G; Maruthupandy M; Manoharan N
Microb Pathog; 2018 Aug; 121():123-130. PubMed ID: 29778819
[TBL] [Abstract][Full Text] [Related]
18. [Study of in vitro activity of 3 cephalosporins and their combination with 2 beta-lactamase inhibitors against 4 enterobacteria strains producing extended spectrum beta-lactamase].
Cattoen C; Duflos D; Bouillet L; Chatelain C; Mazars E
Pathol Biol (Paris); 1997 May; 45(5):425-9. PubMed ID: 9296097
[TBL] [Abstract][Full Text] [Related]
19. An Increase in the clinical isolation of acquired AmpC β-lactamase-producing Klebsiella pneumoniae in Korea from 2007 to 2010.
Park MJ; Kim TK; Song W; Kim JS; Kim HS; Lee J
Ann Lab Med; 2013 Sep; 33(5):353-5. PubMed ID: 24003426
[TBL] [Abstract][Full Text] [Related]
20. Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut.
Tenover FC; Mohammed MJ; Gorton TS; Dembek ZF
J Clin Microbiol; 1999 Dec; 37(12):4065-70. PubMed ID: 10565933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
